SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-032760
Filing Date
2019-08-21
Accepted
2019-08-21 16:39:21
Documents
14
Period of Report
2019-08-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20190821.htm   iXBRL 8-K 45833
2 EX-99.1 fgen-ex991_6.htm EX-99.1 27043
3 GRAPHIC gc3aavo14xqq000001.jpg GRAPHIC 4421
  Complete submission text file 0001564590-19-032760.txt   214629

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fgen-20190821.xsd EX-101.SCH 6201
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20190821_lab.xml EX-101.LAB 19070
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20190821_pre.xml EX-101.PRE 11723
7 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20190821_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191043421
SIC: 2834 Pharmaceutical Preparations